Home > Income Statement > TRIDENT LIFELINE

TRIDENT LIFELINE
Revenue

    Back to Income Statement
TRIDENT LIFELINE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

TRIDENT LIFELINE Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Net Sales ₹87 Cr₹45 Cr₹32 Cr₹22 Cr

What is the latest Revenue of TRIDENT LIFELINE ?

The latest Revenue ratio of TRIDENT LIFELINE is ₹87 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹87 Cr
Mar2024₹45 Cr
Mar2023₹32 Cr
Mar2022₹22 Cr

How is Revenue of TRIDENT LIFELINE Trending?

Years Revenue % Change
Mar2025 ₹87 Cr
94.86
Mar2024 ₹45 Cr
40.82
Mar2023 ₹32 Cr
45.59
Mar2022 ₹22 Cr -

Compare Revenue of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹294.2 Cr -3.4% -4.8% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

-3.4%

-4.8%

-4.8%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses